References in periodicals archive ?
The spectrum of NLRP7 mutations in French patients with recurrent hydatidiform mole.
NLRP7 and the genetics of post-molar choriocarcinomas in Senegal.
NLRP7 and the genetics of hydatidiform moles: recent advances and new challenges.
Novel NLRP7 mutations in familial recurrent hydatidifonn mole: are NLRP7 mutations a risk for recurrent reproductive wastage?
4 in several ethnic groups, (17-19) with the subsequent identification of the causative gene, NLRP7 (nucleotide-binding, leucine-rich repeat, pyrin domain).
Genomic DNA was extracted from peripheral white blood cells and the 11 NLRP7 exons and flanking intronic sequences were amplified by using primers tailed at 5' end with the universal M13 sequence (primers available upon request).
15%) were heterozygous for 4 NLRP7 mutations (Table; Figure 1, C, F, I, and N).
Heterozygous NLRP7 mutations were found in more than 13% of our patients with sporadic hydatidiform moles, associated or not with normal pregnancies.
Our findings are in concordance with those of Deveault et al, (26) who demonstrated that NLRP7 mutations or variants are responsible not only for diploid biparental moles as previously shown, but also for diploid androgenetic moles, triploid moles, and for tetraploid spontaneous abortions.
The exact role of NLRP7 in this pathologic process is poorly understood.
To the best of our knowledge, this report establishes for the first time that oocyte donation can enable women with familial recurrent hydatidiform moles due to NLRP7 mutations to achieve a normal pregnancy," Ms.
The study also shows "that the major role of NLRP7 in pregnancy is in the developing oocyte," they said.
Medical browser ?
- NMDA antagonist
- NMDA receptor
- NMDA receptor antagonists
- NMDA receptors
Full browser ?